CAH · 8-K · 20261105PR000042
Acquisition / Partnership / Divestiture
CARDINAL HEALTH INC · 2026-11-05 · Importance 59 · Surprise 82 · In source text
Cardinal Health said it anticipates completing the acquisition of AdaptHealth’s Diabetes Health business in Q3 of fiscal 2027; the release did not disclose a purchase price. The cash-flow statement reports $149 million of acquisitions of subsidiaries, net of cash acquired, in Q1 FY27, compared with $41 million in Q1 FY26. Cardinal Health also entered a binding letter of intent to renew its pharmaceutical distribution agreements with CVS Health, supporting continued volume growth in Pharmaceutical and Specialty Solutions.
Key facts
- Cardinal Health anticipates completing the acquisition of AdaptHealth’s Diabetes Health business in Q3 of fiscal 2027. source
- Cardinal Health entered into a binding letter of intent to renew its pharmaceutical distribution agreements with CVS Health, enabling continued volume growth within the Pharmaceutical and Specialty Solutions segment. source
- Cardinal Health launched the INSIGHT-IBD real-world evidence study in partnership with Eli Lilly to study treatment patterns and outcomes for patients with IBD in routine clinical practice. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Cardinal Health entered into a binding letter of intent to renew its pharmaceutical distribution agreements with CVS Health, enabling… |